Itraconazole 200mgx14

What is Itraconazole?

Itraconazole is a well-established triazole antifungal that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting this process, it effectively stops fungal growth and treats a wide spectrum of fungal infections. Unlike older antifungals, itraconazole is notable for its broad activity, oral bioavailability, and unique pharmacokinetics, making it a reliable option for both superficial and systemic use.

What makes Itraconazole unique?

In recent years, itraconazole has drawn scientific interest beyond its antifungal role. Research suggests it may exert anti-cancer activity by interfering with angiogenesis (the formation of new blood vessels that feed tumors) and modulating cellular signaling pathways. This dual profile—established safety as an antifungal with emerging evidence of oncological potential—positions itraconazole as a fascinating compound for both clinical and research applications.

Key benefits:

• Proven broad-spectrum antifungal activity
• Oral and systemic effectiveness with strong bioavailability
• Long-standing clinical safety profile
• Unique pharmacological effects on tumor growth and angiogenesis
• Investigational potential in cancer therapy and drug repurposing research

Itraconazole is a broad-spectrum antifungal medication used to treat various fungal infections by inhibiting fungal cell membrane synthesis. Clinical studies have demonstrated its efficacy in treating various cancers as well, with itraconazole enhancing survival rates, reducing tumor growth, and reversing chemoresistance in some cases.